AnGes, Inc.
AMGXFOTCHealthcare● Active
$0.36
+$0.00(+0.00%)
Market Cap$142504592
P/E Ratio—
52W High$0.3602
52W Low$0.3353
AnGes, Inc. (AMGXF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AMGXF · earnings · updated Jun 10, 2026
Latest Earnings
Q2 FY2026Report Date: May 8, 2026EPS Actual
-$0.02
Revenue
$0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 8, 2026
After Market Close
AMGXF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 7, 2026 | — | — | — | — | — | — |
| — Q2 FY2026 | May 8, 2026 | — | -$0.02 | — | $0.00B | — | — |
| — Q1 FY2026 | Feb 10, 2026 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2025 | Nov 7, 2025 | — | -$0.01 | — | $0.00B | — | — |
| — Q3 FY2025 | Aug 8, 2025 | — | -$0.06 | — | $0.00B | — | — |
| — Q2 FY2025 | May 9, 2025 | — | -$0.03 | — | $0.00B | — | — |
| — Q1 FY2025 | Feb 14, 2025 | — | -$0.55 | — | $0.00B | — | — |
| — Q4 FY2024 | Nov 8, 2024 | — | -$0.11 | — | $0.00B | — | — |
Q3 FY2026
Aug 7, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 8, 2026
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2026
Feb 10, 2026
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2025
Nov 7, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2025
Aug 8, 2025
EPS Actual
-$0.06
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
May 9, 2025
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Feb 14, 2025
EPS Actual
-$0.55
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 8, 2024
EPS Actual
-$0.11
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2025 | $0.4B | $0.4B | $0.4B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 8, 2026 | — | $0.36 | $0.36 | +0.00% |
| — Q1 FY2026 | Feb 10, 2026 | — | $0.36 | $0.36 | +0.00% |
| — Q4 FY2025 | Nov 7, 2025 | — | $0.36 | $0.36 | +0.00% |
| — Q3 FY2025 | Aug 8, 2025 | — | $0.36 | $0.36 | +0.00% |
| — Q2 FY2025 | May 9, 2025 | — | $0.36 | $0.36 | +0.00% |
| — Q1 FY2025 | Feb 14, 2025 | — | $0.36 | $0.36 | +0.00% |
| — Q4 FY2024 | Nov 8, 2024 | — | $0.41 | $0.41 | +0.00% |
| — Q3 FY2024 | Aug 9, 2024 | — | No price data | $0.34 | — |
Q2 FY2026+0.00%
Report Date
May 8, 2026
EPS Beat/Miss
—
Price Before
$0.36
Price After
$0.36
Q1 FY2026+0.00%
Report Date
Feb 10, 2026
EPS Beat/Miss
—
Price Before
$0.36
Price After
$0.36
Q4 FY2025+0.00%
Report Date
Nov 7, 2025
EPS Beat/Miss
—
Price Before
$0.36
Price After
$0.36
Q3 FY2025+0.00%
Report Date
Aug 8, 2025
EPS Beat/Miss
—
Price Before
$0.36
Price After
$0.36
Q2 FY2025+0.00%
Report Date
May 9, 2025
EPS Beat/Miss
—
Price Before
$0.36
Price After
$0.36
Q1 FY2025+0.00%
Report Date
Feb 14, 2025
EPS Beat/Miss
—
Price Before
$0.36
Price After
$0.36
Q4 FY2024+0.00%
Report Date
Nov 8, 2024
EPS Beat/Miss
—
Price Before
$0.41
Price After
$0.41
Q3 FY2024—
Report Date
Aug 9, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$0.34
Beat Rate0 / 8 quarters
Largest Move+0.00% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AMGXF ends December
AnGes, Inc. (AMGXF) most recently reported earnings on May 8, 2026 for Q2 FY2026, posting EPS of $-0.02 (in line with the analyst consensus of —).
Each quarter, investors track AMGXF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AMGXF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AMGXF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AMGXF earnings · 4 questionsAnGes, Inc.'s next earnings report is expected around TBD. AMGXF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AMGXF historically reports after market close (AMC).
AMGXF earnings datewhen is AMGXF earningsAMGXF next earnings datewhen does AMGXF report earningsAMGXF earnings calendar
▸ Source: FMP · AnGes, Inc. SEC filings · US GAAP · AnGes, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026